Complete Skin Clearance is Associated with HADS-Defined Absence of Anxiety and Depressive Symptoms After IL-17A Inhibitor Treatment in Moderate-to-Severe Psoriasis: Evidence from the SPEECH Cohort

Zhenquan Xuan, Yingbao Zhen, Didaer Muheyati, Dawei Huang, Lian Cui, Zeyu Chen, Min Dai, Yuxiong Jiang, Yangfeng Ding, Qian Yu, Yuling Shi

Open source

DOI
10.2147/ccid.s633054
Published
2026-09
Container
Clinical, Cosmetic and Investigational Dermatology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ccid.s633054,
  title = {Complete Skin Clearance is Associated with HADS-Defined Absence of Anxiety and Depressive Symptoms After IL-17A Inhibitor Treatment in Moderate-to-Severe Psoriasis: Evidence from the SPEECH Cohort},
  author = {Zhenquan Xuan and Yingbao Zhen and Didaer Muheyati and Dawei Huang and Lian Cui and Zeyu Chen and Min Dai and Yuxiong Jiang and Yangfeng Ding and Qian Yu and Yuling Shi},
  year = {2026},
  journal = {Clinical, Cosmetic and Investigational Dermatology},
  doi = {10.2147/ccid.s633054},
  url = {https://doi.org/10.2147/ccid.s633054}
}

RIS

TY  - JOUR
TI  - Complete Skin Clearance is Associated with HADS-Defined Absence of Anxiety and Depressive Symptoms After IL-17A Inhibitor Treatment in Moderate-to-Severe Psoriasis: Evidence from the SPEECH Cohort
AU  - Zhenquan Xuan
AU  - Yingbao Zhen
AU  - Didaer Muheyati
AU  - Dawei Huang
AU  - Lian Cui
AU  - Zeyu Chen
AU  - Min Dai
AU  - Yuxiong Jiang
AU  - Yangfeng Ding
AU  - Qian Yu
AU  - Yuling Shi
PY  - 2026
JO  - Clinical, Cosmetic and Investigational Dermatology
DO  - 10.2147/ccid.s633054
UR  - https://doi.org/10.2147/ccid.s633054
ER  - 

APA

Xuan, Z., Zhen, Y., Muheyati, D., Huang, D., Cui, L., Chen, Z., Dai, M., Jiang, Y., Ding, Y., Yu, Q., & Shi, Y. (2026). Complete Skin Clearance is Associated with HADS-Defined Absence of Anxiety and Depressive Symptoms After IL-17A Inhibitor Treatment in Moderate-to-Severe Psoriasis: Evidence from the SPEECH Cohort. Clinical, Cosmetic and Investigational Dermatology. https://doi.org/10.2147/ccid.s633054

Source records